Explore end-to-end demos that combine multiple AI endpoints to solve real problems. Each use case runs step-by-step with explanations, evidence, and a final dossier.
End‑to‑end triage of BRCA1 variant with downstream context and actionability.
Assess activating mutations in oncogenes and their downstream functional impacts.
Evaluate gene essentiality and context for selecting therapeutic targets.
End-to-end design of CRISPR therapeutic components: guide RNAs, HDR templates, and safety validation.
Design and optimize therapeutic proteins with enhanced properties for cancer immunotherapy.
Design tissue-specific regulatory elements and optimize expression for targeted gene therapy.
End-to-end personalized therapy design combining target identification, asset generation, and validation.
Explore our API documentation to combine endpoints for your research needs.